Fundraising Fox
Maxion Therapeutics
Cambridge, GB · Founded 2020 · 59 employees on LinkedIn · 4 known investors
Find your way into Maxion Therapeutics
Sign up to find every way you can get introduced to Maxion Therapeutics
- Your email: who you already know at Maxion Therapeutics, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Maxion Therapeutics team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Maxion Therapeutics develops protein and antibody therapeutics using its patented KnotBody technology, which fuses cysteine-rich miniproteins (Knottins) into antibody binding loops to target ion channels and GPCRs. It focuses on first-in-class and best-in-class treatments for diseases driven by ion channel and GPCR dysfunction, including pain, autoimmune and cardiovascular conditions.
Founders & leadership
Maxion Therapeutics was founded in 2020 by John McCafferty and Aneesh Karatt-Vellatt.
Investors · 4
.png)
How we know: General Catalyst's portfolio page · the company's own site · a partner's Signal profile · Not right? Tell us
How we know: LifeArc Ventures's portfolio page · the company's own site · Not right? Tell us
Frequently asked questions
- What does Maxion Therapeutics do?
- Maxion Therapeutics develops protein and antibody therapeutics using its patented KnotBody technology, which fuses cysteine-rich miniproteins (Knottins) into antibody binding loops to target ion channels and GPCRs. It focuses on first-in-class and best-in-class treatments for diseases driven by ion channel and GPCR dysfunction, including pain, autoimmune and cardiovascular conditions.
- Who founded Maxion Therapeutics?
- Maxion Therapeutics was founded by John McCafferty, Aneesh Karatt-Vellatt in 2020.
- Who are Maxion Therapeutics's investors?
- Maxion Therapeutics's investors include General Catalyst, LifeArc Ventures, Monograph Capital Partners, Solasta Ventures.
- Where is Maxion Therapeutics headquartered?
- Maxion Therapeutics is headquartered in Cambridge, GB.